Petauri, a leading purpose-built pharmaceutical services platform, announced today the acquisition of Artia Solutions, a premier consultancy specializing in Medicaid market access and the related dynamic regulatory environment.

HR 1 (2025) is the most significant law affecting Medicare, Medicaid, CHIP, and the ACA marketplace in over a decade. This Summary of the new law, and potential direct and indirect effects on the industry are provided for each provision contained in the law. The Summary also provides an initial assessment on how states will react to the far-ranging policy provisions.

In this look back at the events of 2024, we recap significant events that shaped Medicaid pharmacy practice.

On November 19, 2024, the 2024 Medicaid Rebate Final Rule went into effect. The Final Rule establishes new oversight and enforcement measures for the Medicaid Drug Rebate Program (MDRP), primarily based on the changes introduced by the Medicaid Services Investment and Accountability Act of 2019 (MSIAA).

Registration for Crossroads 2025 is officially open. Crossroads will be held on August 25-27, 2025, in Nashville, Tennessee.

Manufacturers are often intimidated when directed by New York to participate in Medicaid, due to the uniqueness of their programs. We aim to eliminate confusion in navigating these processes to resolution. In this blog post, we’ll walk you through a summary of the most recent changes to the New York Medicaid programs.